SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Item 5.07. ach of the seven (7) director-nominees:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-01-04
Original SEC Filing: Click here


Webplus: SKBI/20110104/8-K/1/000.htm SEC Original: v207255_8k.htm
Item 5.07. ach of the seven (7) director-nominees: Name of Nominee Votes For Votes Withheld Weibing Lu 3,175,125 9,912 Wei Wen 3,175,125 9,912 Mark D. Chen 3,043,441 141,596 R.ott Cramer 3,175,125 9,912 Qiang Fan 3,177,079 7,958 Chengtun Qu 3,182,079 2,958 Shouguo Zhao 3,177,079 7,958ystar Bio-Pharmaceuticalmpany Weibing Lu Chief Executive Officer



Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-01-04CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE

Home Page Forums

By | 2016-02-05T03:47:56+00:00 January 4th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar